Clinical Trials Browser

Phase 2 × Lymphoma × R-CHOP protocol × Clear all

NCT04546620 2026-04-30

REMoDL-A

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03995147 2025-06-08

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00268853 2024-05-30

RAPID

Phase 2 Completed

124 enrolled 13 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02605694 2021-03-17

FRESCO

Phase 2 Withdrawn

Lymphoma